通州市医疗卫生单位消毒质量动态比较观察

对1997～2000年通州市医疗卫生单位消毒质量监测结果进行动态比较,显示消毒质量正在稳步提高,并以2000年为最佳,县级医疗卫生单位明显优于乡镇卫生院。     

肺癌支气管动脉灌注化疗并发症的防治

目的 :探讨肺癌支气管脉灌注化疗 (BAI)并发症产生原因及防治措施。方法 :中晚期肺癌 38例行BAI6 2例次 ,15例次出现并发症。结果 :恶心 ,呕吐 8例次 ,局部皮损 3例次 ,脊髓损伤 2例次。经积极治疗 ,以上并发症均得以控制。结论 :BAI可出现不同并发症 ,应注意预防 ,积极处理     

Effects of diuretics on intradialytic hypotension in maintenance dialysis patients: a systematic review and meta-analysis

Purpose

Intradialytic hypotension (IDH) is a serious complication in dialysis patients. Diuretics might reduce the incidence of IDH by decreasing ultrafiltration. However, the effect of diuretics on IDH in maintenance dialysis patients is still unclear.

Methods

We searched Medline, Embase, the Cochrane Library, China National Knowledge Infrastructure and clinical trials registries from 1945 to May 2019. Randomized controlled trials (RCTs) or observational studies about IDH in maintenance dialysis with diuretics were included.

Results

Seven studies including 28,226 patients were included, of which 4 were RCTs involving mineralocorticoid receptor antagonists (MRAs) and 3 were observational studies involving loop diuretics. There was a trend that a lower incidence rate of IDH in maintenance dialysis patients who used loop diuretics than control, although the result was not statistically significant (OR 0.65, 95% CI 0.34–1.22, P?=?0.18). Similarly, lower incidence rate of all-cause mortality (OR 0.92, 95% CI 0.87–0.99; P?=?0.02) and cardiovascular (CV) mortality (OR 0.86, 95% CI 0.75–0.99, P?=?0.03) in dialysis patients who used loop diuretics than control. On the contrary, there were no significant difference in the incidence of IDH (OR 1.35, 95% CI 0.78–2.34, P?=?0.29) and all-cause mortality (OR 0.73, 95% CI 0.26–2.01; P?=?0.54) and CV mortality (OR 0.57, 95% CI 0.14–2.25; P?=?0.42) in maintenance dialysis patients who used MRAs compared with control.

Conclusion

Loop diuretics, but not MRAs, might have a potential benefit to reduce the incidence rate of IDH, all-cause mortality and CV mortality. More high-quality studies are needed to strengthen the arguments.

     

Surface modification of titanium implant by microarc oxidation and hydrothermal treatment

Surface modification of titanium implant is processed by microarc oxidation and hydrothermal treatment. A porous surface with a biologically active bone-like apatite layer was formed. The apatite layer consists of very fine crystals and high crystallinity and is integrated with the titanium alloy substrate with a graded structure without a distinct interface. Such a bioactive layer is expected not only to enhance the bony ingrowth into the porous structure, but also to improve the interlocking between implant and bone.     

Studies an morphological typing of argyrophilic nucleolar organizer regions

Morphological typing of argyrophilic nucleolar organizer regions (AgNOR) in 300 caws of malignant tumors and 140 cams of benign lesions was analyzed and five morphological types of ApNOR were described in detail. In malignant tumors, the diffuse type (78%) was the most frequently seen, and in benign lesions, the nucleolar type (92.85%); the difference was thus highly significant (P < 0.001). The intranucleolar and aggregate types were not observed in benign lesions. There was no obvious difference in the proportion of the mixed type in benign and malignant lesions (P > 0.05). The relationship between grade of malignancy and morphological typing of AgNOR and its clinical significance are discussed.     

改良的颈神经丛阻滞麻醉的临床观察

目的：探讨甲状腺大部切除手术应用改良的颈神经丛阻滞麻醉效果。方法：全部病例均采用一点法深浅颈神经丛阻滞。将全部病例随机分为A、B两组（每组30例）,深丛均为0.25%布比卡因液或1.14%利多卡因和0.14%地卡因混合液,每侧各约5-6ml。A组为与深丛相同浓度的局麻药液,每侧约8-10ml,B组为与A组所用药同等剂量,但其浓度为A组的2/3（即加入1/3容量的生理盐水）,使浅丛容量较A组增加1/3,约为11-13.5ml。结果：两组病人经过顺利,均无并发症。阻滞效果均较好,但A组病人在手术进行到牵拉甲状腺上极时,有12例病人牵拉痛较明显。结论：低浓度高容量法颈丛阻滞,效果可靠、安全、并发症少,是甲状腺大部切除较理想的麻醉方法。     

实验动物胚胎和合子的低温保存

近40年来,人体的一些重要细胞组织低温保存和移植的逐步成功,低温技术在治疗肿瘤等方面的应用,动植物细胞、胚胎、组织低温保存的发展,已经给医学、生物学、农业、畜牧业等带来了巨大的效益,并使低温生物学、低温医学成为人们关注的新兴交叉科学。在实验动物方面,随着生命科学的飞速发展,实验动物的品种、品系数量也在不断地增加。因此采用胚胎冷冻保存技术,建立实验动物的胚胎库,将是保存实验动物品系和我国特有的动物资源的行之有效的方法。同时也为进行胚胎发育机理研究、转基因动物培育、动物模型培育等创造了条件。     

视盘血管炎的治疗

目的:研究视盘血管炎的发病机制,病因,病程经过,治疗方法及预后.方法:系统治疗和观察了视盘血管炎46例,其中视乳头水肿26例、30眼,中央静脉血栓型20例、20眼.对患者视力、视野、眼压、视乳头改变、眼底荧光血管造影及血象等进行了检查.对视乳头水肿型行CT颅脑扫描,眼压测量和脑脊液检查以除外颅内病变.所有患者均予以抗感染和抑制免疫反应疗法.结果:患者均在18个月内治愈.视乳头水肿型视盘血管炎半数视盘颜色变淡.中央静脉血栓型25%患者视盘颜色变淡,但其视力不下降.全部患者视力均有不同程度地提高.结论:视盘血管炎是一种非特异性内源性血管炎,是对广泛性抗原的过敏反应,抗感染和抑制免疫反应可以缩短病程,提高视力,减少并发症.